Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 29 , ISSUE 2 ( February, 2025 ) > List of Articles

Original Article

Nucleotidase as a Clinical Prognostic Marker in Snakebites: A Prospective Study

Ram S Kaulgud, Tousif Hasan, Muragendraswami Astagimath, Gulamnabi L Vanti, Veeresh S, Mahantesh M Kurjogi, Shivakumar Belur

Keywords : Envenomation, Neurotoxin, Nucleotidase, Snakebite, Snake venom

Citation Information : Kaulgud RS, Hasan T, Astagimath M, Vanti GL, S V, Kurjogi MM, Belur S. Nucleotidase as a Clinical Prognostic Marker in Snakebites: A Prospective Study. Indian J Crit Care Med 2025; 29 (2):125-129.

DOI: 10.5005/jp-journals-10071-24901

License: CC BY-NC 4.0

Published Online: 31-01-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

Background: Snakebite envenomation is a critical global health issue, causing substantial mortality and morbidity. Snake venom includes various enzymes, such as nucleotidase, phosphatases, etc. which impact physiological functions. However, research on the role of serum 5’-nucleotidase levels in assessing the severity and outcomes of snakebites is limited. This study aims to measure serum 5’-nucleotidase levels and explore their correlation with the severity of envenomation, to better understand its role in predicting patient prognosis. Methods: This is a single-center, prospective observational analysis involving 82 snakebite patients. Serum 5’-nucleotidase levels were measured using enzyme-linked immunosorbent assay, and clinical severity was evaluated using the snakebite severity score (SSS). Statistical analyses were performed to determine the correlation between 5’-nucleotidase levels and SSS, as well as various complications. Results: Among the 82 snakebite patients, 71.9% were male and 28.1% were female. Most bites (62.2%) occurred during the day, and 83% involved the lower limbs. Recovery was high, with 93.9% discharged, 3.7% deceased, and 2.4% lost to follow-up. A positive correlation was observed between 5’-nucleotidase levels and SSS at both 0 and 24 hours, with correlation coefficients of 0.55 and 0.61, respectively (p < 0.001). Conclusion: Serum 5’-nucleotidase serves as an effective biomarker for assessing the severity of snakebite envenomation and predicting patient outcomes. Its strong correlation with clinical severity scores makes it a valuable tool for improving the prognostication and management of snakebite cases when used in conjunction with clinical assessments.


PDF Share
  1. World Health Organization. Regional action plan for prevention and control of snakebite envenoming in the South-East Asia 2022–2030. Geneva: World Health Organization; 2022.
  2. Bawaskar HS. Snake bite poisoning: A neglected life-threatening occupational hazard. Indian J Crit Care Med 2014;18:123–124. DOI: 10.4103/0972-5229.128698.
  3. Sachan D. The snake in the room: Snakebite's huge death toll demands a global response. BMJ 2018;5:361. DOI: 10.1136/bmj.k2449.
  4. World Health Organization. Snakebite envenoming: Member states provide WHO with clear mandate for global action. Geneva: World Health Organization; 2018.
  5. Mohapatra B, Warrell DA, Suraweera W, Bhatia P, Dhingra N, Jotkar RM, et al. Snakebite mortality in India: A nationally representative mortality survey. PLoS Negl Trop Dis 2011;5(4):e1018. DOI: 10.1371/journal.pntd.0001018.
  6. World Health Organization. Study estimates more than one million Indians died from snakebite envenoming over past two decades. Geneva: World Health Organization; 2020.
  7. Nallathambi M. A study of clinical and prognostic forecast in snake bite [dissertation]. Thanjavur, Tamil Nadu, India: Thanjavur Medical College; 2017.
  8. Whitaker R, Whitaker S. Analysis of snakebite data from Pappinisseri Vishachikilsa Society, Kannur, Kerala (India). Calicut Med J 2006;4(2):e2. DOI: 10.4103/0028-3886.158155.
  9. Kaulgud RS, Hasan T, Vanti GL, Veeresh S, Uppar AP, Kurjogi MM. Snake venom-specific phospholipase A2: A diagnostic marker for the management of snakebite cases. Indian J Crit Care Med 2022;26(12):1259–1266. DOI: 10.5005/jp-journals-10071-24362.
  10. Dart R, Hurlbut K, Garcia R, Boren J. Snakebite severity score. Toxicon 1996;34(2):145. DOI: 10.1016/0041-0101(96)83658-0.
  11. Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Snake bite in South Asia: A review. PLoS Negl Trop Dis 2010;4(1):e603. DOI: 10.1371/journal.pntd.0000603.
  12. de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol 2016;81(3):446–452. DOI: 10.1111/bcp.12739.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.